INHIBITION OF PROSTATE CANCER CELL LINE (PC-3) BY ANHYDRODIHYDROARTEMISININ (ADHA) THROUGH CASPASE-DEPENDENT PATHWAY

被引:5
作者
Ahmad, Faiz [1 ]
Sarder, Amit [1 ]
Gour, Rajesh [2 ]
Karna, Shibendra Kumar Lal [1 ]
Arora, Priya [1 ]
Kartha, K. P. Ravindranathan [2 ]
Pokharel, Yuba Raj [1 ]
机构
[1] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi 110021, India
[2] Natl Inst Pharmaceut Educ & Res, Dept Med Chem, Sas Nagar 160062, Punjab, India
来源
EXCLI JOURNAL | 2020年 / 19卷
关键词
Anhydrodihydroartemisinin; PC-3; apoptosis; caspase; 3; 7; c-Jun; Akt; NF-kappa B; ARTEMISIA-ANNUA; ANTIMALARIAL; DERIVATIVES;
D O I
10.17179/excli2020-1331
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer is a generic term for a large group of diseases characterized by the growth of abnormal cells, which is the second leading cause of death globally. To treat cancer, currently, a number of anticancer drugs belonging to various classes chemically are available. The discovery of artemisinin and its derivatives such as artesunate, arteether, and artemether became a milestone in the cure for malaria. Here, we report the anti-cancer property of anhydrodihydroartemisinin (ADHA) - a semisynthetic derivative of artemisinin against prostate cancer cell line PC-3. ADHA was found to be inhibiting growth of PC-3 cells. ADHA was also found to be inhibiting migration of PC-3 cells. At molecular level, ADHA was found to be inhibiting the expression of c-Jun, p-c-Jun, p-Akt and NF-kappa B and activated caspase 3 and 7. The results show that ADHA like few other artemisinin derivatives hold potential to be used as an anti-cancer agent against prostate cancer cells.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 27 条
[1]   Perturbations of the AKT signaling pathway in human cancer [J].
Altomare, DA ;
Testa, JR .
ONCOGENE, 2005, 24 (50) :7455-7464
[2]   The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao) [J].
Brown, Geoffrey D. .
MOLECULES, 2010, 15 (11) :7603-7698
[3]   Synthesis of a novel series of artemisinin dimers with potent anticancer activity involving Sonogashira cross-coupling reaction [J].
Buragohain, Pori ;
Saikia, Bishwajit ;
Surineni, Naresh ;
Barua, Nabin C. ;
Saxena, Ajit K. ;
Suri, Nitasha .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (01) :237-239
[4]   Artesunate induces necrotic cell death in schwannoma cells [J].
Button, R. W. ;
Lin, F. ;
Ercolano, E. ;
Vincent, J. H. ;
Hu, B. ;
Hanemann, C. O. ;
Luo, S. .
CELL DEATH & DISEASE, 2014, 5 :e1466-e1466
[5]   Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug [J].
Crespo-Ortiz, Maria P. ;
Wei, Ming Q. .
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2012,
[6]   Artemisinin-derived dimer ART-838 potently inhibited human acute leukemias, persisted in vivo, and synergized with antileukemic drugs [J].
Fox, Jennifer M. ;
Moynihan, James R. ;
Mott, Bryan T. ;
Mazzone, Jennifer R. ;
Anders, Nicole M. ;
Brown, Patrick A. ;
Rudek, Michelle A. ;
Liu, Jun O. ;
Arav-Boger, Ravit ;
Posner, Gary H. ;
Civin, Curt I. ;
Chen, Xiaochun .
ONCOTARGET, 2016, 7 (06) :7268-7279
[7]   Orally active antimalarials:: Hydrolytically stable derivatives of 10-trifluoromethyl anhydrodihydroartemisinin [J].
Grellepois, F ;
Chorki, F ;
Ourévitch, M ;
Charneau, S ;
Grellier, P ;
McIntosh, KA ;
Charman, WN ;
Pradines, B ;
Crousse, B ;
Bonnet-Delpon, D ;
Bégué, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) :1423-1433
[8]   Anhydrodihydroartemisinin and its 10-trifluoromethyl analogue:: Access to novel D-ring-contracted artemisinin trifluoromethyl ketones [J].
Grellepois, F ;
Chorki, F ;
Crousse, B ;
Ourévitch, M ;
Bonnet-Delpon, D ;
Bégué, JP .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (04) :1253-1260
[9]   Ring-contracted artemisinin derivatives:: stereoselective reaction of anhydrodihydroartemisinin towards halogenating reagents [J].
Grellepois, F ;
Bonnet-Delpon, D ;
Bégué, JP .
TETRAHEDRON LETTERS, 2001, 42 (11) :2125-2127
[10]   The complexity of NF-κB signaling in inflammation and cancer [J].
Hoesel, Bastian ;
Schmid, Johannes A. .
MOLECULAR CANCER, 2013, 12